Literature DB >> 29157076

UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells.

Qishu Zhang1, Lijun Qiao1, Xiao Wang2, Changkuan Ding1, Jason J Chen1.   

Abstract

UHRF1 (ubiquitin-like, containing PHD and RING finger domains 1) is an important epigenetic regulator that plays a part in DNA methylation, protein methylation and ubiquitination. It is also frequently overexpressed in many types of cancers, including cervical cancer, which is caused by human papillomavirus (HPV). In this study, we showed that UHRF1 was up-regulated in HPV oncogene E7 expressing cells and HPV-positive cervical cancer cells. We demonstrated that UHRF1 down-regulated the expression of UBE2L6 gene that encodes the ISG15-conjugating enzyme UbcH8. Overexpression of UHRF1 reduced UBE2L6 while knockdown UHRF1 elevated the expression of UBE2L6. We showed that UHRF1 regulated UBE2L6 gene by promoter hypermethylation in cervical cancer cells. Consistent with the functions of UHRF1, restored expression of UbcH8 induced apoptosis. These findings establish UBE2L6 as a novel target of UHRF1 that regulates the apoptosis function of UHRF1. Our studies suggest that UHRF1/ UbcH8 can be manipulated for therapy in cervical cancer.

Entities:  

Keywords:  E7; HPV; UHRF1; UbcH8; apoptosis

Mesh:

Substances:

Year:  2018        PMID: 29157076      PMCID: PMC5914733          DOI: 10.1080/15384101.2017.1403686

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  43 in total

Review 1.  Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

Authors:  Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2011-04-15

2.  Ubiquitin E3 ligase UHRF1 regulates p53 ubiquitination and p53-dependent cell apoptosis in clear cell Renal Cell Carcinoma.

Authors:  Jian Ma; Jingtao Peng; Ren Mo; Shaofei Ma; Jing Wang; Lijuan Zang; Weiguo Li; Jie Fan
Journal:  Biochem Biophys Res Commun       Date:  2015-06-20       Impact factor: 3.575

3.  Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.

Authors:  Cuijuan Zhang; Hiuming Li; Yan Wang; Wenjun Liu; Qinghui Zhang; Tingguo Zhang; Xiaoying Zhang; Bo Han; Gengyin Zhou
Journal:  J Hepatol       Date:  2010-07-14       Impact factor: 25.083

4.  Structural insight into coordinated recognition of trimethylated histone H3 lysine 9 (H3K9me3) by the plant homeodomain (PHD) and tandem tudor domain (TTD) of UHRF1 (ubiquitin-like, containing PHD and RING finger domains, 1) protein.

Authors:  Jingdong Cheng; Yi Yang; Jian Fang; Jianxiong Xiao; Tingting Zhu; Fei Chen; Ping Wang; Ze Li; Huirong Yang; Yanhui Xu
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

5.  Analysis of UHRF1 expression in human ovarian cancer tissues and its regulation in cancer cell growth.

Authors:  Feng Yan; Xiaoming Wang; Lijia Shao; Mengyuan Ge; Xiaoya Hu
Journal:  Tumour Biol       Date:  2015-06-13

Review 6.  Molecular coupling of DNA methylation and histone methylation.

Authors:  Hideharu Hashimoto; Paula M Vertino; Xiaodong Cheng
Journal:  Epigenomics       Date:  2010-10       Impact factor: 4.778

7.  UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer.

Authors:  M Unoki; J D Kelly; D E Neal; B A J Ponder; Y Nakamura; R Hamamoto
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

8.  UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.

Authors:  Wei Jin; Li Chen; Ying Chen; Si-Guang Xu; Gen-Hong Di; Wen-Jin Yin; Jiong Wu; Zhi-Ming Shao
Journal:  Breast Cancer Res Treat       Date:  2009-11-27       Impact factor: 4.872

9.  The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein.

Authors:  Chen Zhao; Sylvie L Beaudenon; Melissa L Kelley; M Brett Waddell; Weiming Yuan; Brenda A Schulman; Jon M Huibregtse; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-06       Impact factor: 11.205

Review 10.  Epigenetic changes in cancer.

Authors:  Kirsten Grønbaek; Christoffer Hother; Peter A Jones
Journal:  APMIS       Date:  2007-10       Impact factor: 3.205

View more
  11 in total

1.  Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women.

Authors:  Emmanouil Papasavvas; Andrew V Kossenkov; Livio Azzoni; Nicola M Zetola; Agnieszka Mackiewicz; Brian N Ross; Matthew Fair; Surya Vadrevu; Doreen Ramogola-Masire; Ian Sanne; Cynthia Firnhaber; Luis J Montaner
Journal:  Carcinogenesis       Date:  2019-04-29       Impact factor: 4.944

Review 2.  Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex.

Authors:  Omeima Abdullah; Ziad Omran; Salman Hosawi; Ali Hamiche; Christian Bronner; Mahmoud Alhosin
Journal:  Genes (Basel)       Date:  2021-04-22       Impact factor: 4.096

3.  Furosine Induced Apoptosis by the Regulation of STAT1/STAT2 and UBA7/UBE2L6 Genes in HepG2 Cells.

Authors:  Huiying Li; Lei Xing; Nan Zhao; Jiaqi Wang; Nan Zheng
Journal:  Int J Mol Sci       Date:  2018-05-31       Impact factor: 5.923

4.  Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.

Authors:  Baohui Hu; Qian Wei; Xueping Li; Mingyi Ju; Lin Wang; Chenyi Zhou; Lianze Chen; Zinan Li; Minjie Wei; Miao He; Lin Zhao
Journal:  Cancer Med       Date:  2020-09-09       Impact factor: 4.452

5.  UHRF1 Induces Methylation of the TXNIP Promoter and Down-Regulates Gene Expression in Cervical Cancer.

Authors:  Min Jun Kim; Han Ju Lee; Mee Young Choi; Sang Soo Kang; Yoon Sook Kim; Jeong Kyu Shin; Wan Sung Choi
Journal:  Mol Cells       Date:  2021-03-31       Impact factor: 5.034

6.  Increased UBE2L6 regulated by type 1 interferon as potential marker in TB.

Authors:  Jiao Gao; Chonghui Li; Wenjing Li; Haotian Chen; Yurong Fu; Zhengjun Yi
Journal:  J Cell Mol Med       Date:  2021-11-12       Impact factor: 5.310

7.  IRF1 association with tumor immune microenvironment and use as a diagnostic biomarker for colorectal cancer recurrence.

Authors:  Yanfang Wu; Shuju Zhang; Jun Yan
Journal:  Oncol Lett       Date:  2020-01-10       Impact factor: 2.967

8.  UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE.

Authors:  Limin Liu; Longyuan Hu; Linxuan Yang; Sujie Jia; Pei Du; Xiaoli Min; Jiali Wu; Haijing Wu; Hai Long; Qianjin Lu; Ming Zhao
Journal:  Clin Epigenetics       Date:  2021-02-10       Impact factor: 6.551

9.  Overexpression of UHRF1 and its potential role in the development of invasive ductal breast cancer validated by integrative bioinformatics and immunohistochemistry analyses.

Authors:  Yichen Yang; Guanjun Liu; Lifang Qin; Li Ye; Fangheng Zhu; Ying Ying
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

10.  Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway.

Authors:  Beina Hui; Shupei Pan; Shaomin Che; Yuchen Sun; Yanli Yan; Jia Guo; Tuotuo Gong; Juan Ren; Xiaozhi Zhang
Journal:  Cancer Manag Res       Date:  2021-06-21       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.